Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
Authors: Lee JH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Kim SH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Kim HR; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea., Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea., Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea., Lee JY; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Moon JH; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Kyungpook National University, 130, Dongduk-Ro, Jung-Gu, Daegu, 41944, Republic of Korea. jhmoon@knu.ac.kr., Kim K; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 81, Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. kihyunkimk@gmail.com.
Source: International journal of hematology [Int J Hematol] 2023 Feb; Vol. 117 (2), pp. 225-235. Date of Electronic Publication: 2022 Nov 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36369635
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SH%22">Kim SH</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HR%22">Kim HR</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Min+CK%22">Min CK</searchLink>; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+HJ%22">Shin HJ</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+JC%22">Jo JC</searchLink>; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Moon+JH%22">Moon JH</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Kyungpook National University, 130, Dongduk-Ro, Jung-Gu, Daegu, 41944, Republic of Korea. jhmoon@knu.ac.kr.<br /><searchLink fieldCode="AU" term="%22Kim+K%22">Kim K</searchLink>; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 81, Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. kihyunkimk@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2023 Feb; Vol. 117 (2), pp. 225-235. <i>Date of Electronic Publication: </i>2022 Nov 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36369635
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12185-022-03479-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 225
    Titles:
      – TitleFull: Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Kim SH
      – PersonEntity:
          Name:
            NameFull: Kim HR
      – PersonEntity:
          Name:
            NameFull: Min CK
      – PersonEntity:
          Name:
            NameFull: Lee JJ
      – PersonEntity:
          Name:
            NameFull: Shin HJ
      – PersonEntity:
          Name:
            NameFull: Jo JC
      – PersonEntity:
          Name:
            NameFull: Lee JY
      – PersonEntity:
          Name:
            NameFull: Moon JH
      – PersonEntity:
          Name:
            NameFull: Kim K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1865-3774
          Numbering:
            – Type: volume
              Value: 117
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International journal of hematology
              Type: main
ResultId 1